| ²é¿´: 422 | »Ø¸´: 2 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
wqssfj1Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
|
[ÇóÖú]
ÇóÖú·Òë
|
|
|
A detailed description of the analysis to be performed will be documented in the study reporting and analysis plan (RAP) analysis plan or in a separate pharmacogenetics RAP, as appropriate. лл£¡ |
» ²ÂÄãϲ»¶
22408 µ÷¼Á²ÄÁÏ
ÒѾÓÐ6È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ19È˻ظ´
277¹¤¿ÆÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
277Çóµ÷¼Á ÊýÒ»104·Ö
ÒѾÓÐ13È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
336Çóµ÷¼Á£¬Ò»Ö¾Ô¸Öпƴó
ÒѾÓÐ6È˻ظ´
071000ÉúÎïѧ£¬Ò»Ö¾Ô¸ÉîÛÚ´óѧ296·Ö£¬Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ19È˻ظ´
sadmissyou
½ð³æ (СÓÐÃûÆø)
- ·ÒëEPI: 27
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1236.3
- ºì»¨: 1
- Ìû×Ó: 165
- ÔÚÏß: 105.2Сʱ
- ³æºÅ: 1461053
- ×¢²á: 2011-10-26
- ÐÔ±ð: GG
- רҵ: »·¾³¹¤³Ì
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
sltmac(½ð±Ò+1): 2011-11-10 12:56:21
sltmac(½ð±Ò+1): 2011-11-10 12:56:21
|
Ò»¸ö¶ÔÓÚ½«ÒªÖ´ÐеķÖÎöµÄÏêϸµÄÃèÊö½«±»¼Ç¼ÓÚÑо¿±¨¸æ¼°·ÖÎöµÄ¼Æ»®ÖУ¬»òÕßÔÚµ¥¶À·Ö¿ªµÄÒ©Îï»ùÒòѧÑо¿±¨¸æ¼°·ÖÎö¼Æ»®ÖУ¬×ÃÇé¶ø¶¨¡£ thank you £º£© ½ö¹©²Î¿¼ |
2Â¥2011-11-10 11:07:37
w1l203
½û³æ (ÎÄ̳¾«Ó¢)
³¾ÊÀÖ®¹â
- ·ÒëEPI: 9
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 344.2
- É¢½ð: 8020
- ºì»¨: 48
- ɳ·¢: 124
- Ìû×Ó: 11234
- ÔÚÏß: 2171.3Сʱ
- ³æºÅ: 470455
- ×¢²á: 2007-11-29
- ÐÔ±ð: GG
- רҵ: ¸ß·Ö×Ó²ÄÁϵļӹ¤Óë³ÉÐÍ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
°®ÓëÓêÏÂ(½ð±Ò+1): 2011-11-10 20:07:12
wqssfj1(½ð±Ò+5, ·ÒëEPI+1): 2011-11-15 13:01:55
°®ÓëÓêÏÂ(½ð±Ò+1): 2011-11-10 20:07:12
wqssfj1(½ð±Ò+5, ·ÒëEPI+1): 2011-11-15 13:01:55
|
A detailed description of the analysis to be performed will be documented in the study reporting and analysis plan (RAP) analysis plan or in a separate pharmacogenetics RAP, as appropriate. лл£¡ ¶ÔÓÚÕâ¸ö¼´½«Íê³ÉµÄ·ÖÎö£¬Ò»·ÝÏêϸµÄ·ÖÎö±¨¸æ»áÐγÉÎļþ£¬¼Ç¼ÔÚÑо¿±¨¸æºÍ·ÖÎö¼Æ»®ÖУ¬»òÕßÔÚÒ»¸öµ¥¶ÀµÄÒÅ´«Ò©ÀíѧµÄ·ÖÎö¼Æ»®±¨¸æÖУ¬½«ÓÚ×ÃÇ鿼ÂÇ¡£ |
3Â¥2011-11-10 15:19:02














»Ø¸´´ËÂ¥